CoChat

Fed‐batch bioreactor process scale‐up from 3‐L to 2,500‐L scale for monoclonal antibody production from cell culture

Yang, Jeng‐Dar, Lu, Canghai, Stasny, Brad, Henley, Joseph, Guinto, Woodrow, Gonzalez, Carlos, Gleason, Joseph, Fung, Monica, Collopy, Brett, Benjamino, Michael, Gangi, Jennifer, Hanson, Melissa, Ille, Elisabeth · 2007 · Biotechnology and Bioengineering
Cited by 100

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Abstract

This case study focuses on the scale‐up of a Sp2/0 mouse myeloma cell line based fed‐batch bioreactor process, from the initial 3‐L bench scale to the 2,500‐L scale. A stepwise scale‐up strategy that involved several intermediate steps in increasing the bioreactor volume was adopted to minimize the risks associated with scale‐up processes. Careful selection of several available mixing models from literature, and appropriately applying the calculated results to our settings, resulted in successful scale‐up of agitation speed for the large bioreactors. Consideration was also given to scale‐up of the nutrient feeding, inoculation, and the set‐points of operational parameters such as temperature, pH, dissolved oxygen, dissolved carbon dioxide, and aeration in an integrated manner. It has been demonstrated through the qualitative and the quantitative side‐by‐side comparison of bioreactor performance as well as through a panel of biochemical characterization tests that the comparability of the process and the product was well controlled and maintained during the process scale‐up. The 2,500‐L process is currently in use for the routine clinical production of Epratuzumab in support of two global Phase III clinical trials in patients with lupus. Today, the 2,500 L, fed‐batch production process for Epratuzumab has met all scheduled batch releases, and the quality of the antibody is consistent and reproducible, meeting all specifications, thus confirming the robustness of the process. Biotechnol. Bioeng. 2007; 98: 141–154. © 2007 Wiley Periodicals, Inc.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/bit.21413

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 100

Metadata

Authors
Yang, J., Lu, C., Stasny, B., Henley, J., Guinto, W., Gonzalez, C., Gleason, J., Fung, M., Collopy, B., Benjamino, M., Gangi, J., Hanson, M., & Ille, E.
Venue
Biotechnology and Bioengineering
Publisher
Wiley
Published
2007-03-09
Volume
98
Issue
1
Pages
141-154
ISSN
  • 0006-3592 (ISSN-L)
  • 1097-0290
OpenAlex
W2170271103
Cited by
100
References
1
FWCI
4.11
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.